Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers

por Saoudi González, Nadia, Castet, Florian, Élez, Elena, Macarulla, Teresa, Tabernero, Josep
Publicado 2022

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer

por Ros, Javier, Saoudi, Nadia, Baraibar, Iosune, Salva, Francesc, Tabernero, Josep, Elez, Elena
Publicado 2022

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

por Ros, Javier, Baraibar, Iosune, Saoudi, Nadia, Rodriguez, Marta, Salvà, Francesc, Tabernero, Josep, Élez, Elena
Publicado 2023

Unveiling changes in the landscape of patient populations in cancer early drug development

por Hierro, Cinta, Azaro, Analía, Argilés, Guillem, Elez, Elena, Gómez, Patricia, Carles, Joan, Rodon, Jordi
Publicado 2016

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer

por Baraibar, Iosune, Mirallas, Oriol, Saoudi, Nadia, Ros, Javier, Salvà, Francesc, Tabernero, Josep, Élez, Elena
Publicado 2021

Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer

por Ros, Javier, Balconi, Francesca, Baraibar, Iosune, Saoudi Gonzalez, Nadia, Salva, Francesc, Tabernero, Josep, Elez, Elena
Publicado 2023

Liver transplantation in metastatic colorectal cancer: are we ready for it?

por Ros, Javier, Salva, Francesc, Dopazo, Cristina, López, Daniel, Saoudi, Nadia, Baraibar, Iosune, Charco, Ramon, Tabernero, Josep, Elez, Elena
Publicado 2023

Correction To: Liver transplantation in metastatic colorectal cancer: are we ready for it?

por Ros, Javier, Salva, Francesc, Dopazo, Cristina, López, Daniel, Saoudi, Nadia, Baraibar, Iosune, Charco, Ramon, Tabernero, Josep, Elez, Elena
Publicado 2023

The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey

por Rodriguez Castells, Marta, Baraibar, Iosune, Ros, Javier, Saoudi, Nadia, Salvà, Francesc, García, Ariadna, Alcaraz, Adriana, Tabernero, Josep, Élez, Elena
Publicado 2023

Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology

por Fernandez Montes, Ana, Elez, Elena, de la Haba-Rodriguez, Juan, Paez, David, Mendez-Vidal, Maria Jose, Felip, Enriqueta, Rodriguez-Lescure, Alvaro
Publicado 2023

SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)

por Fernández Montes, Ana, Alonso, Vicente, Aranda, Enrique, Élez, Elena, García Alfonso, Pilar, Grávalos, Cristina, Maurel, Joan, Vera, Ruth, Vidal, Rosario, Aparicio, Jorge
Publicado 2023

BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer

por Ros, Javier, Baraibar, Iosune, Sardo, Emilia, Mulet, Nuria, Salvà, Francesc, Argilés, Guillem, Martini, Giulia, Ciardiello, Davide, Cuadra, José Luis, Tabernero, Josep, Élez, Elena
Publicado 2021

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications

por Saoudi González, Nadia, Salvà, Francesc, Ros, Javier, Baraibar, Iosune, Rodríguez-Castells, Marta, García, Ariadna, Alcaráz, Adriana, Vega, Sharela, Bueno, Sergio, Tabernero, Josep, Elez, Elena
Publicado 2023

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer

por Martini, Giulia, Dienstmann, Rodrigo, Ros, Javier, Baraibar, Iosune, Cuadra-Urteaga, Jose Luis, Salva, Francesc, Ciardiello, Davide, Mulet, Nuria, Argiles, Guillem, Tabernero, Josep, Elez, Elena
Publicado 2020

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples

por Vivancos, Ana, Aranda, Enrique, Benavides, Manuel, Élez, Elena, Gómez-España, Maria Auxiliadora, Toledano, Marta, Alvarez, Martina, Parrado, Maria Rosario Chica, García-Barberán, Vanesa, Diaz-Rubio, Eduardo
Publicado 2019

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer

por Serna, Garazi, Ruiz-Pace, Fiorella, Cecchi, Fabiola, Fasani, Roberta, Jimenez, Jose, Thyparambil, Sheeno, Landolfi, Stefania, Elez, Elena, Vivancos, Ana, Hembrough, Todd, Tabernero, Josep, Dienstmann, Rodrigo, Nuciforo, Paolo
Publicado 2019

BRAF (V600E)/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

por Colle, Raphael, Lonardi, Sara, Cachanado, Marine, Overman, Michael J, Elez, Elena, Fakih, Marwan, Corti, Francesca, Jayachandran, Priya, Svrcek, Magali, Dardenne, Antoine, Cervantes, Baptiste, Duval, Alex, Cohen, Romain, Pietrantonio, Filippo, André, Thierry
Publicado 2023

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

por García-Foncillas, Jesús, Tabernero, Josep, Élez, Elena, Aranda, Enrique, Benavides, Manuel, Camps, Carlos, Jantus-Lewintre, Eloisa, López, Rafael, Muinelo-Romay, Laura, Montagut, Clara, Antón, Antonio, López, Guillermo, Díaz-Rubio, Eduardo, Rojo, Federico, Vivancos, Ana
Publicado 2018

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer

por Moutinho, Catia, Martinez-Cardús, Anna, Santos, Cristina, Navarro-Pérez, Valentin, Martínez-Balibrea, Eva, Musulen, Eva, Carmona, F. Javier, Sartore-Bianchi, Andrea, Cassingena, Andrea, Siena, Salvatore, Elez, Elena, Tabernero, Josep, Salazar, Ramon, Abad, Albert, Esteller, Manel
Publicado 2013

Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-depende...

por Kefford, Richard, Sullivan, Ryan J, Miller, Wilson H, Elez, Elena M, Tan, Daniel, Kim, Kevin B, Long, Georgina V, Flaherty, Keith T, Tai, David, Stutvoet, Simone, Maacke, Heiko, Whiley, Matt, Parseval, Laure Moutouh-de, Tabernero, Josep
Publicado 2014